# Orion S.A. (OEC) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Chemicals. Price $6.09, market value $343 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Orion S.A. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.2×**. Each dollar of revenue is priced at 0.2×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 9.6×**. Enterprise value is 9.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 7.4%** (5-yr avg -0.1%). Free cash flow equals 7.4% of the market value, above its five-year average of -0.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Gross margin: 18.4%**. Orion S.A. keeps 18.4% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -0.2%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -3.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -18.2%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -0.2%**. Return on all capital, debt included, is -0.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -5.0%**. Each dollar of assets produces -5.0% of profit.

## Growth
- **Revenue growth (1 yr): -3.8%** (3-yr -3.8%/yr, 5-yr 9.7%/yr). Revenue fell 3.8% over the last year, against 9.7% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -263.2%**. Earnings per share fell 263.2%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 2.55**. Debt is 2.55 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 7.0×**. It would take 7.0 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 1.36%** ($0.08 per share, trailing). Orion S.A. yields 1.36%, a modest yield more typical of a growth-oriented payer.
- **Dividend growth (5 yr): -16.0%/yr** (1-yr -0.4%). The dividend has not grown over five years.

## Price and momentum
- **Total return (1 yr): -40.3%** (YTD 16.6%, 3-mo -8.8%). The shares are down 40.3% over twelve months including dividends.
- **From 52-week high: -42.4%** (40.2% above the low). Trading 42% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 1.19** (volatility 67%). Beta of 1.19 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OEC · Page: https://foliofundamentals.com/stocks/oec

Not investment advice.